Molecular Templates Inc. Presents Preclinical Data On CD38-Targeted Engineered Toxin Body (ETB) At The American Association For Cancer Research Special Conference, Hematologic Malignancies: Translating Discoveries To Novel Therapies

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GEORGETOWN, Texas--(BUSINESS WIRE)--Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapies, announced today that it presented preclinical data in a poster presentation at the American Association for Cancer Research special conference, Hematologic Malignancies: Translating Discoveries to Novel Therapies, held September 20-23rd, 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news